RGNX
Regenxbio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.57
-0.51 ▼ -5.62%
🌙 3월 13일 6:56 PM ET (한국 3/14 07:56)
$8.44
-0.13 ▼ -1.52%
| Index | RUT | P/E | - | EPS (ttm) | -3.75 | Insider Own | 10.98% | Shs Outstand | 0.05B | Perf Week | -0.92% |
| Market Cap | 0.44B | Forward P/E | - | EPS next Y | -30.46% | Insider Trans | -0.59% | Shs Float | 0.05B | Perf Month | 0.82% |
| Enterprise Value | 0.47B | PEG | - | EPS next Q | -1.34 | Inst Own | 78.47% | Short Float | 13.9% | Perf Quarter | -34.38% |
| Income | -0.19B | P/S | 2.6 | EPS this Y | 42.83% | Inst Trans | 0.25% | Short Ratio | 6.56 | Perf Half Y | -9.69% |
| Sales | 0.17B | P/B | 4.25 | EPS next 5Y | 28.05% | ROA | -42.19% | Short Interest | 6.39M | Perf YTD | -40.49% |
| Book/sh | 2.02 | P/C | 1.92 | EPS past 3/5Y | 16.67% -4.73% | ROE | -107% | 52W High | -47.07% ($16.19) | Perf Year | 30.84% |
| Cash/sh | 4.46 | P/FCF | - | Sales past 3/5Y | 14.78% 1.97% | ROIC | -61.48% | 52W Low | 70.21% ($5.03) | Perf 3Y | -58.76% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 19.06% | Gross Margin | 78.93% | Volatility(W/M) | 8.31% 8.04% | Perf 5Y | -78.98% |
| Dividend TTM | - | EV/Sales | 2.77 | Sales Y/Y TTM | 104.54% | Oper. Margin | -94.58% | ATR (14) | 0.86 | Perf 10Y | -33.67% |
| Dividend Ex-Date | - | Quick Ratio | 2.38 | EPS Q/Q | -25.61% | Profit Margin | -113.75% | RSI (14) | 41.96 | Recom | 1.42 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.38 | Sales Q/Q | 43% | SMA20 | -1.82% ($8.73) | Beta | 1.12 | Target Price | $29.25 |
| Payout | - | Debt/Eq | 2.54 | Earnings | 3000000 | SMA50 | -22.98% ($11.13) | Rel Volume | 1.09 | Prev Close | $9.08 |
| Employees | 371 | LT Debt/Eq | 2.07 | EPS/Sales Surpr. | -35.97% -30.99% | SMA200 | -18.95% ($10.57) | Avg Volume(3M) | 0.97M | Price | $8.57 |
| IPO | 2015/9/17 | Option/Short | Yes/Yes | Trades | 8112 | Volume | 1,058,135 | Change | -5.62% |
뉴스 로딩 중...